CLINICAL_TRIALS
trial_result
· 2014-04-29
Clinical Trial Update: A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects [Phase 4]
Summary
A 12-week Phase 4 trial comparing pitavastatin 4 mg versus pravastatin 40 mg in HIV-infected subjects with dyslipidemia; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kowa Research Institute, Inc. | Conditions: Dyslipidemia | Phase 4 | Status: COMPLETED | Results posted: 2014-04-29